EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at
Experience Project.
Joined: Feb 19, 2006 Posts: 358 Location: suburb of Chicago, IL USA
Posted: Thu Jan 25, 2007 6:03 pm Post subject: CHR-1103
Chromos reports preclinical data in support of CHR-1103 as an acute therapy for relapse associated with multiple sclerosis
Brain Pathology paper has implications for treatment of MS.
Chromos Molecular Systems Inc. announced today the publication of a paper entitled "Modulation of Experimental Autoimmune Encephalomyelitis by VLA-2 Blockade" in the peer-reviewed scientific journal, Brain Pathology. This paper, authored in collaboration with Dr. Robert Fujinami of the University of Utah School of Medicine, demonstrates that a monoclonal antibody directed against VLA-2, the target for Chromos' lead product candidate CHR-1103, can suppress the clinical and pathological signs of disease in a relevant animal model of multiple sclerosis (MS). In addition, the publication validates VLA-2 as a potential target for early therapeutic intervention in the treatment of MS. This data represents a significant milestone in the development of CHR-1103 as an acute treatment for relapses associated with MS.
"We are very pleased with the release of this data as it represents the culmination of a tremendous body of work in support of the development of CHR-1103 as an acute treatment for MS relapse," said Alistair Duncan, President and CEO. "Currently, there are no FDA approved therapies for MS patients suffering from a relapse. CHR-1103 represents a promising new approach for the treatment of MS relapse and disease compared to the existing portfolio of chronically administered treatments."
CHR-1103 is a humanised monoclonal antibody being developed as a broad-based anti-inflammatory agent, with an initial focus on the treatment of acute relapses associated with MS. Unlike therapeutics designed to delay or antagonise the initial stages of inflammation, CHR-1103 is designed to reduce and prevent the accumulation of inflammatory cells within inflamed tissues. This distinction, i.e., the targeting of ongoing inflammation with CHR-1103, may provide a significant advantage for the acute treatment of inflammatory conditions and/or diseases.
Chromos completed its first meeting with officials from the U.S. Food and Drug Administration (FDA) for CHR-1103 in Q3 2006. The two parties discussed Chromos' clinical approach, proposed preclinical safety evaluation program and manufacture of CHR-1103. Chromos is now moving forward with preclinical safety evaluation studies in preparation for an Investigational New Drug (IND) application in Q4 2007.
Joined: May 04, 2006 Posts: 3456 Location: Mid-Michigan
Posted: Thu Jan 25, 2007 7:03 pm Post subject: Tinkerbell on Speed
RTL 1000 and CHR-1103
Wow, you're turning into a whirling dervish.....whatever that is.
Thanks Scooby...or whoever I am responding to.
He of mushbrain,
Bob
Later edit* I looked up whirling dervish up on the internet and you're not one...sorry! I guess I had previously thought it meant like a tireless female or super energetic fairy or something.
Joined: Feb 19, 2006 Posts: 358 Location: suburb of Chicago, IL USA
Posted: Sat Jan 27, 2007 1:14 pm Post subject:
Bob, I'm just glad you got my name right That day happened to be a good day for MS research news. Personally I like to think of myself as an investigative crusader for MS!! Not really since I barely understand half the stuff I post Most of the time I have to wait until others can explain it to me. Research progress is what keeps me going.
Joined: May 04, 2006 Posts: 3456 Location: Mid-Michigan
Posted: Sat Jan 27, 2007 1:25 pm Post subject:
scoobyjude wrote:
Personally I like to think of myself as an investigative crusader for MS!! Not really since I barely understand half the stuff I post
Hi Scoob,
I know where you're coming from, I've said many times that I'm in over my head. I have no choice but to avoid the really technical stuff. I can't understand ANY of that.
Bob
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum
We encourage you to also visit our Multiple Sclerosis story and support community on Experience Project.
Experience Project is a vast and powerful community where people connect anonymously through life experiences. It's made by the same people who built This is MS,
on the premise that no one life experience-- like having MS-- defines a person. It now covers over 2 million life stories. Find and share yours!
Forum FAQ
Search
Usergroups
Profile
Log in to check your private messages
Log in
That day happened to be a good day for MS research news. Personally I like to think of myself as an investigative crusader for MS!! Not really since I barely understand half the stuff I post 
Most of the time I have to wait until others can explain it to me. Research progress is what keeps me going.